We understand the hope tied to a procedure like bariatric surgery, and we also understand the emerging science thats providing powerful, less invasive paths to the same goal
Semaglutide works by mimicking the hormone glucagon-like peptide 1 (GLP-1), and is currently authorized for the treatment of type 2 diabetes patients with insufficient glycaemic control and long-term weight management
After six months, the goal shifts from repair to optimization. Long-term users generally report a higher baseline of health
Discussion The global prevalence of obesity is surging at an unprecedented rate, emerging as a major public health crisis and a key driver of metabolic disorders, including T2DM
Some individuals may experience gradual results as the medication is introduced, while others might notice immediate effects
It slows down how fast your stomach empties, so that you feel fuller while also increasing how much insulin your pancreas produces which lowers blood sugar